Abstract:The use of propranolol for the treatment of infantile hemangioma (IH) has been widely investigated in recent years. However, the underlying therapeutic mechanism of propranolol for the treatment of IH remains poorly understood. The aim of the present study was to investigate the expression of proteins regulated by cellular tumor antigen p53 (p53) in associated apoptosis pathways in IH endothelial cells (HemECs) treated with propranolol. Furthermore, the present study aimed to investigate the exact apoptotic pathway underlying the therapeutic effect of propranolol against IH. In the present study, HemECs were subcultured and investigated using an inverted phase contrast microscope, immunocytochemical staining and a scanning electron microscope (SEM). Experimental groups and blank control groups were prepared. All groups were subjected to drug treatment. A high p53 expression model of HemECs was successfully established via transfection, and a low p53 expression model of HemECs was established using pifithrin-α. The apoptosis rate of each group was determined using Annexin V-fluorescein isothiocyanate/propidium iodide double staining and flow cytometry. The expression levels of downstream proteins regulated by p53 [tumour necrosis factor receptor superfamily member 6 (FAS), p53-induced death domain-containing protein (PIDD), death receptor 5 (DR5), BH3-interacting domain death agonist (BID), apoptosis regulator BAX (BAX), p53 unregulated modulator of apoptosis (PUMA), phosphatidylinositol-glycan biosynthesis class S protein (PIGS), and insulin-like growth factor-binding protein 3 (IGF-BP3)] were revealed in the experimental and control groups via western blotting. Microscopic observation revealed the growth of an adherent monolayer of cells, which were closely packed and exhibited contact inhibition. Immunocytochemical staining demonstrated increased expression of clotting factor VIII. SEM analysis revealed presence of Weibel-Palade bodies. The results of the analyses verified that the cultured cells were HemECs. The staining of the samples resulted in a significantly increased rate of apoptosis in experimental groups compared with the blank control group. This result suggested that there is an association between p53 expression and the rate of apoptosis of propranolol-treated HemECs. The results of the western blot analysis demonstrated an upregulation of BAX expression and a downregulation of IGF-BP3 expression in the HemECs treated with propranolol. There were no significant differences in the expression levels of FAS, DR5, PIDD, BID, PUMA and PIGS between experimental and control groups. This result suggests that p53 has an important role in HemEC apoptosis. The results of the present study additionally suggest that the propranolol-induced HemEC apoptosis pathway is a mitochondrial apoptosis pathway and is regulated by p53-BAX signaling.

[Effects of propranolol on the biological behavior of human umbilical vein endothelial cells and the expression of SOX18, MMP-7, and VEGFA]

Research of Effects of Propranolol in Human Vascular Endothelial Cell

Effect of propranolol on apoptosis and VEGF, bFGF expression of hemangioma-derived stem cells

Effects of Puerarin on Thrombin-Induced-proliferation of Vascular Smooth Muscle Cells and the Role of Puerarin on the TR Mrna Expression

[Effects of Propranolol on Proliferation of Hemangioma-Derived Mesenchymal Stem Cells ].

Research of the mechanisms of propranolol in the treatment of hemangiomas

Propranolol Induces Apoptosis of Human Umbilical Vein Endothelial Cells Through Down-Regulation of CD147

Effect of propranolol on the proliferation,apoptosis and cell cycle of gastric carcinoma cells

Propranolol Inhibits Endothelial Progenitor Cell Homing: a Possible Treatment Mechanism of Infantile Hemangioma.

The research for P53.MDM2 in propranolol-induced apoptosis in hemangioma endothelial cell

Effects of Propranolol and Timolol on Proliferation and Apoptosis of Hemangioma Stem Cells

Propranolol Inhibits Angiogenesis Via Down-Regulating the Expression of Vascular Endothelial Growth Factor in Hemangioma Derived Stem Cell

Combinative effects of β -elemene and propranolol on the proliferation, migration, and angiogenesis of hemangioma

Efficacy and adverse effects of oral propranolol in infantile hemangioma: a meta-analysis of comparative studies

Propranolol Induces Hemangioma Endothelial Cell Apoptosis Via a P53-Bax Mediated Pathway

Induction of apoptosis in infantile hemangioma endothelial cells by propranolol.

Clinical efficacy of oral propranolol for the treatment of infant proliferating hemangiomas and the changes of serum VEGF

Effect of Brazilian propolis on human umbilical vein endothelial cell apoptosis

Effects of Bisoprolol on nitric oxide production by endothelial cells during anoxia/reoxygenation

Propranolol represses infantile hemangioma cell growth through the β2-adrenergic receptor in a HIF-1α-dependent manner.

Effects of Propofol on the Changes in Cytoskeleton and Cellular Permeability of Human Umbilical Vascular Endothelial Cells Monolayer Induced by Lipopolysaccharide